Rory Horner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rory Horner has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Yuko Aoyama
Clark University
5 shared publications - David Hulme
University of Manchester
2 shared publications - Seth Schindler
The University of Manchester
2 shared publications - Balaji Parthasarathy
Centre for Information Technology and Public Policy, International Institute of Information Technology, Bangalore, India
1 shared publication Bish Sanyal
Department of Urban Studies and Planning, Massachusetts Institute of Technology, Cambridge, MA
1 shared publication- Charlotte Lemanski
University of Cambridge
1 shared publication
Latest Publications
- 8 May 2025
- Published by Edward Elgar Publishing
- p. 105-118
The economic geography of global health: insights from pharmaceuticals and other medical goods
- 8 May 2025
- Published by Edward Elgar Publishing
- p. 105-118
The economic geography of global health: insights from pharmaceuticals and other medical goods
- 8 May 2025
- Published by Edward Elgar Publishing
- p. 1-12
Economic geography for the 21st century: an introduction
- 8 May 2025
- Published by Edward Elgar Publishing
- p. 1-12
Economic geography for the 21st century: an introduction
- Top Cited PapersOpen Access
- 1 November 2024
- Published by Walter de Gruyter GmbH in ZFW – Advances in Economic Geography
- Vol. 68 (3-4) , 145-150
Driving Change in Troubling Times: Security, Risk and the State in Global Production Networks
This editorial revisits the state – global production network (GPN) nexus in times of multiple crises affecting the global economy and society. Setting the scene, we first reflect on the role of geopolitics in transforming GPNs under conditions of increasing uncertainty before turning our attention to the ways in which states deal with questions of security and navigate risk. It also highlights the increasingly overt role of strategic state strategies vis-a-vis GPNs. In a second step, we discuss the central, constitutive role of the state in processes of strategic coupling, decoupling and recoupling, before presenting some concluding thoughts.
- 1 November 2024
- Published by Walter de Gruyter GmbH in ZFW – Advances in Economic Geography
- Vol. 68 (3-4) , 145-150
Top Cited PapersOpen AccessDriving Change in Troubling Times: Security, Risk and the State in Global Production Networks
This editorial revisits the state – global production network (GPN) nexus in times of multiple crises affecting the global economy and society. Setting the scene, we first reflect on the role of geopolitics in transforming GPNs under conditions of increasing uncertainty before turning our attention to the ways in which states deal with questions of security and navigate risk. It also highlights the increasingly overt role of strategic state strategies vis-a-vis GPNs. In a second step, we discuss the central, constitutive role of the state in processes of strategic coupling, decoupling and recoupling, before presenting some concluding thoughts.
- Open Access
- 6 April 2021
- Published by Springer Nature in Journal of International Business Policy
- Vol. 5 (1) , 68-87
Global value chains, import orientation, and the state: South Africa’s pharmaceutical industry
As opposed to the predominant focus of global value chain (GVC) research on export-oriented contexts, this article examines the prospects for development in places where the dominant form of engagement with GVCs is import-oriented. Through the case of South Africa’s pharmaceutical industry, this analysis demonstrates the challenge for local manufacturing to compete, and the associated state policy responses, in a place which is largely plugged into GVCs as an end market rather than as a production location. As multinationals have concentrated production elsewhere, South Africa’s manufacturing capacity in the pharmaceutical industry has relatively declined in recent decades. Having struggled in its facilitator role, the South African state’s efforts to promote local manufacturing have turned to the producer role through a state-owned company and especially the buyer role through public procurement. Motivations for state policy in this context, however, must navigate the tension which sometimes exists between the industrial interest in local manufacturing and the consumer and health policy interest in access to medicines. The experience of South Africa’s pharmaceutical industry points to the wider challenge and consequences of import-oriented engagement with GVCs for local industrial development.
- 6 April 2021
- Published by Springer Nature in Journal of International Business Policy
- Vol. 5 (1) , 68-87
Open AccessGlobal value chains, import orientation, and the state: South Africa’s pharmaceutical industry
As opposed to the predominant focus of global value chain (GVC) research on export-oriented contexts, this article examines the prospects for development in places where the dominant form of engagement with GVCs is import-oriented. Through the case of South Africa’s pharmaceutical industry, this analysis demonstrates the challenge for local manufacturing to compete, and the associated state policy responses, in a place which is largely plugged into GVCs as an end market rather than as a production location. As multinationals have concentrated production elsewhere, South Africa’s manufacturing capacity in the pharmaceutical industry has relatively declined in recent decades. Having struggled in its facilitator role, the South African state’s efforts to promote local manufacturing have turned to the producer role through a state-owned company and especially the buyer role through public procurement. Motivations for state policy in this context, however, must navigate the tension which sometimes exists between the industrial interest in local manufacturing and the consumer and health policy interest in access to medicines. The experience of South Africa’s pharmaceutical industry points to the wider challenge and consequences of import-oriented engagement with GVCs for local industrial development.
- Open Access
Beyond rebranding from international to global? Lessons from geographies of global health for global development
With the potential for a major geographic shift from international to global development as paradigm for development studies and practice, this paper seeks to draw lessons from the closely related field of health as to what a shift from “international” to “global” may involve. In both fields, an earlier “international” framing emerges from a state‐dominated system which, although it superseded prior colonial origins, is outdated vis‐à‐vis an ability to fully reflect the contemporary range of actors and problems in a more interdependent context. Little agreement is present over the definition of global health, where the “global” is deployed in multiple ways and often involving only a modest shift in geographical imaginary from international health. The case highlights the potential of such an “international” to “global” shift being a 21st‐century rebranding, which captures some aspects of change but remains a partial perspective on present challenges that are global in scope. It is concluded that the shift from “international” to “global” in development must go beyond rebranding to address a wider range of 21st‐century development challenges.
Open AccessBeyond rebranding from international to global? Lessons from geographies of global health for global development
With the potential for a major geographic shift from international to global development as paradigm for development studies and practice, this paper seeks to draw lessons from the closely related field of health as to what a shift from “international” to “global” may involve. In both fields, an earlier “international” framing emerges from a state‐dominated system which, although it superseded prior colonial origins, is outdated vis‐à‐vis an ability to fully reflect the contemporary range of actors and problems in a more interdependent context. Little agreement is present over the definition of global health, where the “global” is deployed in multiple ways and often involving only a modest shift in geographical imaginary from international health. The case highlights the potential of such an “international” to “global” shift being a 21st‐century rebranding, which captures some aspects of change but remains a partial perspective on present challenges that are global in scope. It is concluded that the shift from “international” to “global” in development must go beyond rebranding to address a wider range of 21st‐century development challenges.
- 27 May 2020
- Published by SAGE Publications in Competition & Change
- Vol. 25 (1) , 124-126
Gereffi G, Global Value Chains and Development: Redefining the Contours of 21st Century Capitalism (2018)
- 27 May 2020
- Published by SAGE Publications in Competition & Change
- Vol. 25 (1) , 124-126
Gereffi G, Global Value Chains and Development: Redefining the Contours of 21st Century Capitalism (2018)
- 14 October 2019
- Published by Taylor & Francis in Canadian Journal of Development Studies / Revue canadienne d'études du développement
- Vol. 41 (2) , 337-338
Multipolar globalization: emerging economies and development
(2019). Multipolar globalization: emerging economies and development. Canadian Journal of Development Studies / Revue canadienne d'études du développement. Ahead of Print.
- 14 October 2019
- Published by Taylor & Francis in Canadian Journal of Development Studies / Revue canadienne d'études du développement
- Vol. 41 (2) , 337-338
Multipolar globalization: emerging economies and development
(2019). Multipolar globalization: emerging economies and development. Canadian Journal of Development Studies / Revue canadienne d'études du développement. Ahead of Print.
- 10 October 2019
- Published by Edward Elgar Publishing
The roles of the state in global value chains
While understanding the influence of private governance through global lead firms has been a defining feature of global value chain (GVC) analysis, the state has often been implicitly observed as part of the broader institutional context shaping GVCs. More recently, however, the state-GVC nexus has attracted more explicit attention. Drawing on insights from GVC research, the chapter highlights four roles of the state within GVCs: as facilitator, regulator, producer and buyer - and outlines key issues on the research agenda in relation to each role. While the facilitator role has received considerable attention and the regulator role is a growing focus, those of producer and buyer are relatively underexplored. The chapter concludes that the contemporary reformulation of economic globalization means the state-GVC nexus is, and will continue to be, especially significant in shaping development outcomes.
- 10 October 2019
- Published by Edward Elgar Publishing
The roles of the state in global value chains
While understanding the influence of private governance through global lead firms has been a defining feature of global value chain (GVC) analysis, the state has often been implicitly observed as part of the broader institutional context shaping GVCs. More recently, however, the state-GVC nexus has attracted more explicit attention. Drawing on insights from GVC research, the chapter highlights four roles of the state within GVCs: as facilitator, regulator, producer and buyer - and outlines key issues on the research agenda in relation to each role. While the facilitator role has received considerable attention and the regulator role is a growing focus, those of producer and buyer are relatively underexplored. The chapter concludes that the contemporary reformulation of economic globalization means the state-GVC nexus is, and will continue to be, especially significant in shaping development outcomes.
- 29 May 2019
- Published by Springer Nature
- p. 275-304
India’s Pharmaceutical Industry and the Enduring Public Regulation Challenge
- 29 May 2019
- Published by Springer Nature
- p. 275-304
India’s Pharmaceutical Industry and the Enduring Public Regulation Challenge